
Upstart (UPST) reported strong Q2 financial results, with revenue of $257.3 million and an adjusted EBITDA profit of $53.1 million, both significantly exceeding estimates. The company achieved a 'Rule of 40' score of 123, surpassing Palantir's 94, driven by 102% revenue growth and a 21% adjusted EBITDA margin. Despite this robust performance and raised full-year guidance, the stock declined, attributed by analysts to a shrinking take rate (9% from 12% YoY) raising concerns about revenue conversion efficiency. However, Upstart attributes this decline to a strategic expansion into lower-risk super prime, auto, and home loan markets, suggesting a long-term growth opportunity that the article implies makes the sell-off a potential buying opportunity.
Upstart (UPST) reported exceptional second-quarter results that sharply contrasted with the subsequent negative stock performance. The company demonstrated significant operational momentum, with revenue growing 102% year-over-year to $257.3 million, handily beating analyst estimates of $225.4 million. This was driven by a 159% jump in loan transaction volume and an improved loan application conversion rate, which rose from 15.2% to 23.9%. On a key software industry metric, the 'Rule of 40', Upstart posted a score of 123, substantially outperforming peer Palantir's 94. Despite this, and a raised full-year forecast, the stock declined due to investor concerns over a shrinking take rate, which fell from 12% to 9% year-over-year. The company attributes this margin compression to a strategic move into the lower-risk super prime loan market and its nascent, but rapidly expanding, auto and home loan segments, where originations grew over sixfold and ninefold, respectively. This performance was achieved without the tailwind of lower interest rates, suggesting a potential for further acceleration if macroeconomic conditions become more favorable.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment